Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
CivaTech Oncology
Mayo Clinic
Abramson Cancer Center at Penn Medicine
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
Centre Jean Perrin
University of Southern California
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
TuHURA Biosciences, Inc.
University of Missouri-Columbia
Center for Biomedical Research, Inc.
Northwestern University
Rhode Island Hospital
Johns Hopkins University
Mayo Clinic
Washington University School of Medicine
Mayo Clinic
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
University of Pittsburgh
Stanford University
University of Pittsburgh
University of Pennsylvania
Washington University School of Medicine
University of Virginia
Case Comprehensive Cancer Center
Northwestern University
Mayo Clinic
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Siemens Molecular Imaging